Literature DB >> 16414356

Regulation by sphingosine 1-phosphate of Bax and Bad activities during apoptosis in a MEK-dependent manner.

Susan Betito1, Olivier Cuvillier.   

Abstract

Herein we report that the prosurvival sphingolipid sphingosine 1-phosphate regulates the activities of both Bad and Bax during apoptosis of Jurkat cells. First, sphingosine 1-phosphate treatment results in Bad inactivation via the ERK/Rsk-1 pathway. Second, sphingosine 1-phosphate blocks the translocation of Bax to the mitochondria induced by Fas ligation. MEK inhibition by PD98059 or U0126 not only abrogates sphingosine 1-phosphate-induced Bad phosphorylation, but also its cytoprotective effect. Furthermore, inhibition of both mitochondrial cytochrome c efflux and Bax translocation to the mitochondria by sphingosine 1-phosphate could be overcome by PD98059 or U0126. Hence, the MEK/ERK pathway seems to be crucial for the survival effects initiated by sphingosine 1-phosphate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16414356     DOI: 10.1016/j.bbrc.2005.12.138

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  2-Acetyl-5-tetrahydroxybutyl imidazole (THI) protects 661W cells against oxidative stress.

Authors:  Carlotta Fabiani; Aida Zulueta; Fabiola Bonezzi; Josefina Casas; Riccardo Ghidoni; Paola Signorelli; Anna Caretti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-04-13       Impact factor: 3.000

Review 2.  Cancer treatment strategies targeting sphingolipid metabolism.

Authors:  Babak Oskouian; Julie D Saba
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 3.  Sphingosine 1-phosphate and cancer.

Authors:  Nigel J Pyne; Susan Pyne
Journal:  Nat Rev Cancer       Date:  2010-06-17       Impact factor: 60.716

Review 4.  S1P metabolism in cancer and other pathological conditions.

Authors:  Weng In Leong; Julie D Saba
Journal:  Biochimie       Date:  2010-02-16       Impact factor: 4.079

5.  Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction.

Authors:  Che-Chung Yeh; Hongzhe Li; Deepak Malhotra; Mei-Chuan Huang; Bo-Qing Zhu; Edward J Goetzl; Donald A Vessey; Joel S Karliner; Michael J Mann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-20       Impact factor: 4.733

6.  Sphingosine 1-phosphate (S1P) promotes mitochondrial biogenesis in Hep G2 cells by activating Peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α).

Authors:  Zhixin Shen; Chong Liu; Pingping Liu; Jiamin Zhao; Wanpeng Xu
Journal:  Cell Stress Chaperones       Date:  2013-12-01       Impact factor: 3.667

7.  The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cells.

Authors:  David G Watson; Francesca Tonelli; Manal Alossaimi; Leon Williamson; Edmond Chan; Irina Gorshkova; Evgeny Berdyshev; Robert Bittman; Nigel J Pyne; Susan Pyne
Journal:  Cell Signal       Date:  2013-01-11       Impact factor: 4.315

8.  A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia.

Authors:  Steven W Paugh; Barbara S Paugh; Mohamed Rahmani; Dmitri Kapitonov; Jorge A Almenara; Tomasz Kordula; Sheldon Milstien; Jeffrey K Adams; Robert E Zipkin; Steven Grant; Sarah Spiegel
Journal:  Blood       Date:  2008-05-29       Impact factor: 22.113

9.  Morphine-induced MOR-1X and ASF/SF2 Expressions Are Independent of Transcriptional Regulation: Implications for MOR-1X Signaling.

Authors:  Patrick M Regan; Ilker K Sariyer; T Dianne Langford; Prasun K Datta; Kamel Khalili
Journal:  J Cell Physiol       Date:  2015-12-28       Impact factor: 6.384

Review 10.  Regulating survival and development in the retina: key roles for simple sphingolipids.

Authors:  Nora P Rotstein; Gisela E Miranda; Carolina E Abrahan; O Lorena German
Journal:  J Lipid Res       Date:  2010-01-25       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.